Roche Holding AG

RHO5

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    103,249

Roche Holding AG News & Analysis

stocks

Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?

‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,028.80106.801.20%
CAC 407,650.1818.170.24%
DAX 4023,854.4696.770.41%
Dow JONES (US)44,173.6442.660.10%
FTSE 1009,152.7824.480.27%
HKSE24,873.28139.830.57%
NASDAQ21,053.58403.451.95%
Nikkei 22540,549.54258.840.64%
NZX 50 Index12,877.04193.001.52%
S&P 5006,329.9491.931.47%
S&P/ASX 2008,770.40106.701.23%
SSE Composite Index3,617.6034.290.96%

Market Movers